Rocklage Scott M's Form 4 filing
Pear Therapeutics, Inc. (PEAR) · filed Aug 18, 2022
- Accession no.
- 0001209191-22-046773
- Filed
- Aug 18, 2022, 8:05 PM ET
- Trade date
- Aug 16-18, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $660.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rocklage Scott MCIK 0001219014 | 10% Owner |
| Diekman John DCIK 0001240357 | 10% Owner |
| 5AM Partners IV, LLCCIK 0001589314 | 10% Owner |
| 5AM Ventures IV, L.P.CIK 0001589315 | 10% Owner |
| 5AM Co-Investors IV, L.P.CIK 0001593361 | 10% Owner |
| Schwab Andrew J.CIK 0001598549 | 10% Owner |
| 5AM Opportunities I, L.P.CIK 0001753000 | 10% Owner |
| 5AM Opportunities I (GP), LLCCIK 0001790778 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2022 | Class A Common Stock | SSaleDisposed | −160,476 | $1.78 | −$285,647.28 | 14,488,165 | Indirect | |
| Aug 16, 2022 | Class A Common Stock | SSaleDisposed | −6,686 | $1.78 | −$11,901.08 | 603,675 | Indirect | |
| Aug 17, 2022 | Class A Common Stock | SSaleDisposed | −9,674 | $1.71 | −$16,542.54 | 14,478,491 | Indirect | |
| Aug 17, 2022 | Class A Common Stock | SSaleDisposed | −403 | $1.71 | −$689.13 | 603,272 | Indirect | |
| Aug 18, 2022 | Class A Common Stock | SSaleDisposed | −213,851 | $1.55 | −$331,469.05 | 14,264,640 | Indirect | |
| Aug 18, 2022 | Class A Common Stock | SSaleDisposed | −8,910 | $1.55 | −$13,810.5 | 594,362 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.